Table 1.
Characteristics of the articles included in the systematic review (k = 212)
| Characteristics | Median [IQR] | Range (min - max) |
|---|---|---|
| Year of publication (year) | 2010 [2007–2013] | 1997 - 2014 |
| Sample size (N)a | 129 [56–359] | 1 - 9105 |
| Sample mean age (year)a | 58 [52–64] | 11 - 77 |
| Sample mean percentage of female (%) | 61 [41–100] | 0 - 100 |
| Number of articles (k) | Percentage (%) | |
| Country where participants came from | ||
| Canada | 110 | 51.9 |
| USA | 65 | 30.7 |
| Australia | 11 | 5.2 |
| UK | 9 | 4.2 |
| Other countriesb,c | 17 | 8.0 |
| Cancer site | ||
| Breast | 61 | 28.8 |
| Prostate | 19 | 9.0 |
| Colorectal | 16 | 7.5 |
| Lung | 12 | 5.7 |
| Hematological (leukemia, myeloma) | 10 | 4.7 |
| Hodgkin/non-Hodgkin lymphoma | 8 | 3.8 |
| Endometrial | 7 | 3.3 |
| Brain/glioma | 7 | 3.3 |
| Head/neck/oral cavity | 5 | 2.4 |
| Ovarian | 5 | 2.4 |
| Kidney | 5 | 2.4 |
| Bladder | 3 | 1.4 |
| Survivors from different types of cancer | 54 | 25.5 |
The unit of observation is the published article. IQR: 25th-75th interquartile range. k: number of published articles included in the systematic review. a k = 211 due to missing information in one article; for all the other variables, k = 212. bOne study included participants from Canada and USA (k = 1; 0.5 %) and one study included participants from Australia and New Zealand (k = 1; 0.5 %). cOther countries included New Zealand (k = 4; 1.9 %), Ireland (k = 3; 1.4 %), Norway (k = 3; 1.4 %), Taiwan (k = 3; 1.4 %), Spain (k = 2; 0.9 %) and Italy (k = 1; 0.5 %).